272 related articles for article (PubMed ID: 22850059)
21. The 2009 A (H1N1) influenza virus pandemic: A review.
Girard MP; Tam JS; Assossou OM; Kieny MP
Vaccine; 2010 Jul; 28(31):4895-902. PubMed ID: 20553769
[TBL] [Abstract][Full Text] [Related]
22. Generation and evaluation of the trivalent inactivated reassortant vaccine using human, avian, and swine influenza A viruses.
Du N; Li W; Li Y; Liu S; Sui Y; Qu Z; Wang Y; Du Y; Xu B
Vaccine; 2008 Jun; 26(23):2912-8. PubMed ID: 18448208
[TBL] [Abstract][Full Text] [Related]
23. Towards integrated production of an influenza A vaccine candidate with MDCK suspension cells.
Bissinger T; Wu Y; Marichal-Gallardo P; Riedel D; Liu X; Genzel Y; Tan WS; Reichl U
Biotechnol Bioeng; 2021 Oct; 118(10):3996-4013. PubMed ID: 34219217
[TBL] [Abstract][Full Text] [Related]
24. Comparison of immunogenicity of cell-and egg-passaged viruses for manufacturing MDCK cell culture-based influenza vaccines.
Shin D; Park KJ; Lee H; Cho EY; Kim MS; Hwang MH; Kim SI; Ahn DH
Virus Res; 2015 Jun; 204():40-6. PubMed ID: 25892718
[TBL] [Abstract][Full Text] [Related]
25. Swine flu vaccines: reaching the finish line.
Davies J
Cell; 2009 Oct; 139(3):449-51. PubMed ID: 19879829
[TBL] [Abstract][Full Text] [Related]
26. Swine flu outbreak. New details on virus's promiscuous past.
Cohen J
Science; 2009 May; 324(5931):1127. PubMed ID: 19478151
[No Abstract] [Full Text] [Related]
27. Vaccine decisions loom for new flu strain.
Butler D
Nature; 2009 May; 459(7244):144-5. PubMed ID: 19444174
[No Abstract] [Full Text] [Related]
28. Developing cell culture-derived pandemic vaccines.
Barrett PN; Portsmouth D; Ehrlich HJ
Curr Opin Mol Ther; 2010 Feb; 12(1):21-30. PubMed ID: 20140813
[TBL] [Abstract][Full Text] [Related]
29. Pandemic influenza A (H1N1) 2009 vaccine: an update.
Goel MK; Goel M; Khanna P; Mittal K
Indian J Med Microbiol; 2011; 29(1):13-8. PubMed ID: 21304188
[TBL] [Abstract][Full Text] [Related]
30. In vitro assessment of the allergenicity of novel MF59-adjuvanted pandemic H1N1 influenza vaccine produced in dog kidney cells.
Bencharitiwong R; Leonard S; Tsai T; Nowak-Węgrzyn A
Hum Vaccin Immunother; 2012 Jul; 8(7):863-5. PubMed ID: 22777093
[TBL] [Abstract][Full Text] [Related]
31. Influenza vaccination and intention to receive the pandemic H1N1 influenza vaccine among healthcare workers of British Columbia, Canada: a cross-sectional study.
Kaboli F; Astrakianakis G; Li G; Guzman J; Donovan T; Naus M
Infect Control Hosp Epidemiol; 2010 Oct; 31(10):1017-24. PubMed ID: 20707670
[TBL] [Abstract][Full Text] [Related]
32. Protective efficacy of intranasal cold-adapted influenza A/New Caledonia/20/99 (H1N1) vaccines comprised of egg- or cell culture-derived reassortants.
Palker T; Kiseleva I; Johnston K; Su Q; Toner T; Szymkowiak C; Kwan WS; Rubin B; Petrukhin L; Wlochowski J; Monteiro J; Kraiouchkine N; DiStefano D; Rudenko L; Shaw A; Youil R
Virus Res; 2004 Oct; 105(2):183-94. PubMed ID: 15351492
[TBL] [Abstract][Full Text] [Related]
33. Swine flu pandemic. Developing countries to get some H1N1 vaccine--but when?
Enserink M
Science; 2009 Nov; 326(5954):782. PubMed ID: 19892952
[No Abstract] [Full Text] [Related]
34. Establishment of Vero cell RNA polymerase I-driven reverse genetics for Influenza A virus and its application for pandemic (H1N1) 2009 influenza virus vaccine production.
Song MS; Baek YH; Pascua PNQ; Kwon HI; Park SJ; Kim EH; Lim GJ; Choi YK
J Gen Virol; 2013 Jun; 94(Pt 6):1230-1235. PubMed ID: 23486669
[TBL] [Abstract][Full Text] [Related]
35. The resurgence of swine-origin influenza A (H1N1).
Mossad SB
Cleve Clin J Med; 2009 Jun; 76(6):337-43. PubMed ID: 19487554
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of novel disposable bioreactors on pandemic influenza virus production.
Lai CC; Weng TC; Tseng YF; Chiang JR; Lee MS; Hu AY
PLoS One; 2019; 14(8):e0220803. PubMed ID: 31404117
[TBL] [Abstract][Full Text] [Related]
37. Vaccination against influenza: role and limitations in pandemic intervention plans.
Rebmann T; Zelicoff A
Expert Rev Vaccines; 2012 Aug; 11(8):1009-19. PubMed ID: 23002981
[TBL] [Abstract][Full Text] [Related]
38. Aflunov(®): a prepandemic influenza vaccine.
Gasparini R; Amicizia D; Lai PL; Panatto D
Expert Rev Vaccines; 2012 Feb; 11(2):145-57. PubMed ID: 22309663
[TBL] [Abstract][Full Text] [Related]
39. Vaccines against influenza A (H1N1) pandemic.
Valdespino-Gomez JL; Garcia-Garcia L; de León-Rosales SP
Arch Med Res; 2009 Nov; 40(8):693-704. PubMed ID: 20304259
[TBL] [Abstract][Full Text] [Related]
40. Strategies for developing vaccines against H5N1 influenza A viruses.
Horimoto T; Kawaoka Y
Trends Mol Med; 2006 Nov; 12(11):506-14. PubMed ID: 17011235
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
